查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1401821

氣喘治療市場，按藥物類別、按產品類型、按給藥途徑、按國家和地區分類 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Asthma Therapeutics Market, By Drug Class, By Product Type, By Route of Administrations, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年氣喘治療市場規模為 241 億美元，2023 年至 2030 年複合CAGR為 5.1%。

氣喘治療市場-市場動態

呼吸系統疾病的激增以及對具有成本效益的治療方案的需求推動了市場需求

呼吸系統疾病的激增以及對具有成本效益的治療方案的需求凸顯了氣喘治療的重要性。根據世界衛生組織 (WHO) 2023 年 5 月的報告，2019 年約有 2.62 億人受到氣喘影響，導致全球 455,000 人死亡。污染、過敏原、灰塵等室內和室外觸發因素的增加以及生活方式的改變等因素預計將推動氣喘治療領域的成長。此外，提高患者、護理人員和醫生對氣喘的認知和教育可能會增強治療效果。每年舉行的世界氣喘大會等活動旨在向專家傳播知識和進展，幫助理解這種疾病並推進治療方案。針對氣喘患者的新型藥物和設備（例如生物製劑、生物相似藥、吸入器、霧化器和智慧型設備）的研發（R＆D）投資預計將加強氣喘管理並促進市場擴張。值得注意的是，BiosanaPharma 完成了奧馬珠單抗生物相似藥的第一期臨床試驗，奧馬珠單抗是 FDA 批准的治療氣喘和慢性特發性蕁麻疹的藥物。這些突破對於增加患者獲得治療選擇至關重要。

氣喘治療市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2023-2030 年）每年將以 5.1% 左右的CAGR成長

根據藥物類別細分，預計聯合療法將在 2022 年顯示最大的市場佔有率

依產品類型細分，2022年吸入型為主導類型

按地區分類，北美是 2022 年的主要收入來源

氣喘治療市場-細分分析：

全球氣喘治療市場根據藥物類別、產品類型、給藥途徑和地區進行細分。

根據藥物類別，市場分為三類：聯合療法、抗發炎藥物和支氣管擴張劑。 2022 年，聯合治療領域，特別是吸入性皮質類固醇與長效 BETA 受體激動劑的聯合治療，在治療類別中佔據了主要市場佔有率。該類藥物因其增強的治療效果、廣泛的可用性以及提高患者對藥物的依從性而受到讚譽。

市場依給藥途徑分為三類：口服、吸入和其他方法。 2022年，由於氣喘治療策略中肺部給藥系統的採用率較高且患者依從性提高，吸入藥物領域佔據了最大的收入佔有率。患者對氣喘替代療法的認知不斷提高，以及與這些先進藥物傳遞系統相關的簡單性，正在推動該細分市場在預估期間內的成長。

氣喘治療市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲地區。這些區域根據開展業務的國家進一步分類。

氣喘治療市場-競爭格局：

製藥和醫療保健領域專門從事氣喘治療的公司採用多種策略來增強其產品。他們的重點仍然是持續研究和開發 (R&D)，以創新和推出新的藥物、配方和輸送系統。這涉及開發針對特定發炎途徑的新藥物或引入先進的吸入器技術以更有效地給藥。公司優先考慮進行臨床試驗和實證研究，以展示其氣喘藥物的有效性和安全性。獲得監管部門的批准並遵守嚴格的標準對於市場滲透和接受至關重要。此外，人們越來越重視個人化醫療方法，旨在根據患者個體特徵、遺傳學和對治療的反應來客製化治療方法。這包括深入研究生物標記和預測分析，以確定可能從特定藥物或療法中獲益更多的患者亞群。此外，行銷策略的重點是向醫療保健提供者和患者宣傳氣喘管理的最新進展，強調遵守治療計劃和提高對可用選擇的認知的重要性。此外，公司積極參與合作和夥伴關係，與研究機構、倡導團體和醫療保健組織合作，推動創新、加強患者護理並擴大市場佔有率。主要行業參與者正在實施各種業務策略來鞏固自己的地位，包括新產品發布、獲得批准以及進行收購和合併。

最近的發展：

2022 年 2 月，Mankind Pharma 透露與 Dr. Reddy's Laboratories Ltd. 達成協議，收購 Combihale 和 Daffy。用於治療氣喘和慢性阻塞性肺病的吸入器品牌Combihale估值為1.09億美元，成長率為14%。這項策略性舉措預計將增強該公司的產品組合，並賦予其相對於競爭對手的競爭優勢。

目錄

第1章：氣喘治療市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按藥物類別分類的氣喘治療市場片段
    • 按產品類型分類的氣喘治療市場片段
    • 依給藥途徑分類的氣喘治療市場片段
    • 按國家/地區分類的氣喘治療市場摘要
    • 按地區分類的氣喘治療市場片段
  • 競爭洞察

第 3 章：氣喘治療主要市場趨勢

  • 氣喘治療市場促進因素
    • 市場促進因素的影響分析
  • 氣喘治療市場限制
    • 市場限制影響分析
  • 氣喘治療市場機會
  • 氣喘治療市場未來趨勢

第 4 章：氣喘治療產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：氣喘治療市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：氣喘治療市場格局

  • 2022 年氣喘治療市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：氣喘治療市場 - 按藥物類別

  • 概述
    • 按藥物類別分類的細分市場佔有率分析
    • 消炎劑
    • 支氣管擴張劑
    • 聯合療法

第 8 章：氣喘治療市場 - 依產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 吸入器
    • 霧化器

第 9 章：氣喘治療市場 - 按給藥途徑

  • 概述
    • 按給藥途徑分類的細分市佔率分析
    • 口服
    • 吸入
    • 其他

第 10 章：氣喘治療市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美哮喘治療主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按藥物類別）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模與預測（按管理途徑）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲氣喘治療主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按藥物類別）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模與預測（按管理途徑）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區氣喘治療主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模和預測（按藥物類別）
    • 亞太地區市場規模與預測（依產品類型）
    • 亞太地區市場規模與預測（依管理途徑）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲哮喘治療主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按藥物類別）
    • 拉丁美洲市場規模與預測（按產品類型）
    • 拉丁美洲市場規模與預測（按管理途徑）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲氣喘治療主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按藥物類別）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（按管理途徑）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 氣喘治療產業

  • 競爭儀表板
  • 公司簡介
    • Teva Pharmaceutical Industries Ltd.
    • GSK plc.
    • Merck& Co., Inc.
    • F. Hoffmann-La Roche Ltd
    • AstraZeneca
    • Boehringer Ingelheim International GmbH.
    • Sanofi
    • Koninklijke Philips NV
    • BD
    • Sunovion Pharmaceuticals, Inc.
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2007

REPORT HIGHLIGHT

Asthma Therapeutics Market size was valued at USD 24,100 Million in 2022, expanding at a CAGR of 5.1% from 2023 to 2030.

Asthma therapeutics encompass a spectrum of medicines and interventions devised to manage and relieve the symptoms of asthma, a persistent respiratory condition marked by airway inflammation and increased responsiveness. These therapies aim to regulate manifestations like wheezing, breath shortness, chest constriction, and coughing. They fall into two primary categories: long-term control drugs that aim to prevent symptoms and diminish airway inflammation, and quick-relief or rescue medications for immediate relief during asthma attacks. Long-term control medications commonly involve inhaled corticosteroids, long-acting beta-agonists, leukotriene modifiers, and biologics, while short-acting beta-agonists and anticholinergics are typically used as rescue drugs. Additionally, treatment plans may incorporate tailored approaches, lifestyle adjustments, and educational programs on managing asthma to enhance individuals' control and enhance their quality of life while reducing the risk of asthma flare-ups. Consistent monitoring and adjustment of treatment by healthcare professionals are crucial for effective asthma care.

Asthma Therapeutics Market- Market Dynamics

Surge in respiratory illnesses alongside the demand for cost-efficient treatment options to propel market demand

The surge in respiratory illnesses alongside the demand for cost-efficient treatment options underlies the significance of asthma therapeutics. According to the World Health Organization's (WHO) May 2023 report, approximately 262 million people were affected by asthma in 2019, resulting in 455,000 global deaths. Factors such as increasing indoor and outdoor triggers like pollution, allergens, dust, and evolving lifestyles are anticipated to drive growth in the asthma therapeutics sector. Furthermore, heightened awareness and education about asthma among patients, caregivers, and medical practitioners are likely to augment treatments. Events like the World Congress of Asthma, held annually to disseminate knowledge and advancements among experts, aid in comprehending the disease and advancing treatment options. Investments in research and development (R&D) for novel drugs and devices catering to asthma patients, such as biologics, biosimilars, inhalers, nebulizers, and smart devices, are expected to enhance asthma management and promote market expansion. Notably, BiosanaPharma completed phase 1 clinical trials for a biosimilar to omalizumab, an FDA-approved drug for asthma and chronic idiopathic urticaria. Such breakthroughs are pivotal in enhancing patient access to treatment options.

Asthma Therapeutics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.1% over the forecast period (2023-2030)

Based on Drug Class segmentation, combination therapy was predicted to show maximum market share in the year 2022

Based on Product Type segmentation, inhaled was the leading type in 2022

On the basis of region, North America was the leading revenue generator in 2022

Asthma Therapeutics Market- Segmentation Analysis:

The Global Asthma Therapeutics Market is segmented on the basis of Drug Class, Product Type, Route of Administrations, and Region.

The market is divided into three categories based on Drug Class: combination therapy, anti-inflammatory drugs, and bronchodilators. In 2022, the combination therapy segment, notably the combination of inhaled corticosteroids with long-acting beta-agonists, held the primary market share within the therapeutic class. This class is acclaimed for its amplified therapeutic effects, widespread availability, and improved patient adherence to medication.

The market is divided into three categories based on route of administration: oral, inhaled, and other methods. In 2022, the inhaled drugs segment claimed the largest revenue share due to the higher adoption rates and improved patient compliance with pulmonary drug delivery systems in asthma treatment strategies. The escalating awareness among patients regarding alternative asthma therapies and the simplicity associated with these advanced drug delivery systems are driving the growth of this segment over the projected period.

Asthma Therapeutics Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Asthma Therapeutics Market- Competitive Landscape:

Companies specializing in asthma therapeutics in the pharmaceutical and healthcare sectors employ diverse strategies to enhance their offerings. Their focus remains steadfast on continuous research and development (R&D) to innovate and introduce new medications, formulations, and delivery systems. This involves creating novel drugs targeting specific inflammatory pathways or introducing advanced inhaler technologies for more effective drug administration. Companies prioritize conducting clinical trials and evidence-based studies to showcase the efficacy and safety of their asthma medications. Obtaining regulatory approvals and complying with rigorous standards are critical for market penetration and acceptance. Moreover, there is a burgeoning emphasis on personalized medicine approaches, intending to customize treatments based on individual patient characteristics, genetics, and responses to therapies. This includes delving into biomarkers and predictive analytics to identify patient subgroups that may benefit more from specific medications or therapies. Furthermore, marketing strategies center on educating healthcare providers and patients about the latest advancements in asthma management, emphasizing the importance of adhering to treatment plans and increasing awareness about available options. Additionally, companies actively engage in collaborations and partnerships, collaborating with research institutions, advocacy groups, and healthcare organizations to drive innovation, enhance patient care, and broaden their market presence. Key industry players are implementing various business strategies to fortify their positions, including new product launches, obtaining approvals, and engaging in acquisitions and mergers.

Recent Developments:

In February 2022, Mankind Pharma revealed an agreement with Dr. Reddy's Laboratories Ltd. to obtain Combihale and Daffy. Combihale, an inhaler brand used for treating asthma and COPD, was valued at USD 109 million with a growth rate of 14%. This strategic move is anticipated to bolster the company's product portfolio and confer a competitive advantage against its rivals.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ASTHMA THERAPEUTICS MARKET KEY PLAYERS

  • Teva Pharmaceutical Industries Ltd.
  • GSK plc.
  • Merck& Co., Inc.
  • F. Hoffmann-La Roche Ltd
  • AstraZeneca
  • Boehringer Ingelheim International GmbH.
  • Sanofi
  • Koninklijke Philips N.V.
  • BD
  • Sunovion Pharmaceuticals, Inc.
  • Others

GLOBAL ASTHMA THERAPEUTICS MARKET, BY DRUG CLASS

  • Anti-inflammatory
  • Bronchodilators
  • Combination Therapy

GLOBAL ASTHMA THERAPEUTICS MARKET, BY PRODUCT TYPE

  • Inhaler
  • Nebulizers

GLOBAL ASTHMA THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATIONS

  • Oral
  • Inhaled
  • Others

GLOBAL ASTHMA THERAPEUTICS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Asthma Therapeutics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Asthma Therapeutics Market Snippet by Drug Class
    • 2.1.2. Asthma Therapeutics Market Snippet by Product Type
    • 2.1.3. Asthma Therapeutics Market Snippet by Route of Administration
    • 2.1.4. Asthma Therapeutics Market Snippet by Country
    • 2.1.5. Asthma Therapeutics Market Snippet by Region
  • 2.2. Competitive Insights

3. Asthma Therapeutics Key Market Trends

  • 3.1. Asthma Therapeutics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Asthma Therapeutics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Asthma Therapeutics Market Opportunities
  • 3.4. Asthma Therapeutics Market Future Trends

4. Asthma Therapeutics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Asthma Therapeutics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Asthma Therapeutics Market Landscape

  • 6.1. Asthma Therapeutics Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Asthma Therapeutics Market - By Drug Class

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Class, 2022 & 2030 (%)
    • 7.1.2. Anti-inflammatory
    • 7.1.3. Bronchodilators
    • 7.1.4. Combination Therapy

8. Asthma Therapeutics Market - By Product Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 8.1.2. Inhaler
    • 8.1.3. Nebulizers

9. Asthma Therapeutics Market - By Route of Administration

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
    • 9.1.2. Oral
    • 9.1.3. Inhaled
    • 9.1.4. Others

10. Asthma Therapeutics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Asthma Therapeutics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Asthma Therapeutics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Asthma Therapeutics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Asthma Therapeutics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Asthma Therapeutics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Asthma Therapeutics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Teva Pharmaceutical Industries Ltd.
    • 11.2.2. GSK plc.
    • 11.2.3. Merck& Co., Inc.
    • 11.2.4. F. Hoffmann-La Roche Ltd
    • 11.2.5. AstraZeneca
    • 11.2.6. Boehringer Ingelheim International GmbH.
    • 11.2.7. Sanofi
    • 11.2.8. Koninklijke Philips N.V.
    • 11.2.9. BD
    • 11.2.10. Sunovion Pharmaceuticals, Inc.
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Asthma Therapeutics Market: Drug Class Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Class
  • TABLE Global Asthma Therapeutics Market, by Drug Class 2018-2030 (USD Million)
  • TABLE Asthma Therapeutics Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Asthma Therapeutics Market, by Product Type 2018-2030 (USD Million)
  • TABLE Asthma Therapeutics Market: Route of Administration Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Asthma Therapeutics Market, by Route of Administration 2018-2030 (USD Million)
  • TABLE Asthma Therapeutics Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Asthma Therapeutics Market, by Region 2018-2030 (USD Million)
  • TABLE North America Asthma Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Asthma Therapeutics Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE North America Asthma Therapeutics Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Asthma Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe Asthma Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Asthma Therapeutics Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Europe Asthma Therapeutics Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Asthma Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific Asthma Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Asthma Therapeutics Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Asia Pacific Asthma Therapeutics Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Asthma Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America Asthma Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Asthma Therapeutics Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Latin America Asthma Therapeutics Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Asthma Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Asthma Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Asthma Therapeutics Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Asthma Therapeutics Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Asthma Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)